Go Wish Game to support advance care planning for adults with cancer or blood cancers
The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco-hematologic Disease (Onco-hema Go Wish-ACP): Intervention Set up and Multicentre Feasibility Trial
This project tries the Go Wish Game to help adults with refractory leukemia, lymphoma, multiple myeloma, or advanced solid tumors and their caregivers have end-of-life conversations and complete advance care planning.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 75 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | Azienda USL Reggio Emilia - IRCCS Government |
| Locations | 1 site (Reggio Emilia) |
| Trial ID | NCT06795815 on ClinicalTrials.gov |
What this trial studies
This mixed-method, device- and drug-free interventional project uses the Go Wish Game—a deck of cards listing concrete end-of-life priorities—to prompt values-based conversations between patients, caregivers, and clinicians. It enrolls adults (≥18) with refractory lymphomas, leukemia, multiple myeloma, or advanced solid tumors and an estimated prognosis greater than three months who can communicate in Italian and provide written consent. The primary aim is to test the feasibility of delivering the card-based intervention in hematology and oncology settings across participating centers. Quantitative measures and qualitative interviews will capture acceptability, uptake, and whether advance care planning documentation is completed.
Who should consider this trial
Good fit: Ideal candidates are Italian-speaking adults (≥18) with refractory lymphoma, leukemia, multiple myeloma, or advanced solid tumors, with estimated prognosis >3 months, who can communicate and give written consent and do not have severe cognitive impairment or serious psychiatric illness.
Not a fit: Patients with severe cognitive impairment or serious psychiatric conditions, those unable to communicate in Italian or provide written consent, or those with very limited prognosis are unlikely to benefit from this intervention.
Why it matters
Potential benefit: If successful, this approach could make it easier for seriously ill patients and their families to express care preferences and increase completion of advance care planning documents, improving alignment of care with patient wishes.
How similar studies have performed: Previous studies of the Go Wish Game and other card-based advance care planning tools have shown promise in increasing end-of-life conversations and documentation, but evidence specifically in onco-hematologic populations remains limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥ 18 years age; diagnosed with refractory lymphomas, or leukemia or multiple myeloma or advanced solid tumors and estimated prognosis \> 3 months; * able to communicate in Italian and * to give written consent to the study. Exclusion Criteria: * Patients with severe cognitive impairment or serious psychiatric condition; * refusal to participate to the study
Where this trial is running
Reggio Emilia
- AziendaUSL IRCCS Reggio Emilia — Reggio Emilia, Italy (Recruiting)
Study contacts
- Study coordinator: Marta Perin (Dr), PhD
- Email: marta.perin@ausl.re.it
- Phone: +39 3463576133
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.